The HRPP FYI Process and the UPIRSO/SAE Review Sheet An IRB Infoshort February 2014.

Slides:



Advertisements
Similar presentations
Managing Compliance Related to Human Subjects Research Review Joseph Sherwin, Ph.D. Office of Regulatory Affairs University of Pennsylvania Fourth Annual.
Advertisements

Tips to a Successful Monitoring Visit
Investigational Device Exemptions 21 CFR Part 812
Gerald Treiman, IRB Chair John Stillman, IRB Director Maureen Brinkman, IRB Administrator Ann Johnson, IRB Administrator.
What is a Data and Safety Monitoring Plan and how do I get one? Presented by Office of Human Research Protection.
Open Library June 4, 2004 Informed Consent Process and Federal Regulations That Must Be Met to Waive Informed Consent Tracey Craddock Regulatory Compliance.
Protocol Deviations : Identification, Responses and Solutions The Office of Human Subjects Research’s Compliance Monitoring Program Educational Seminars:
UTHSC IRB Donna Hollaway, RN, CCRC 11/30/2011 Authority to Audit 45 CFR (e) An IRB shall conduct continuing review of research covered by this.
USF Research Integrity & Compliance eIRB Comprehensive Training 10/07/2014.
Submission to Approval What happens to my protocol once I submit it to the HIC office.
IRB Determinations 1. AAHRPP Site Visit Results Site visitors observed a real commitment to human subject protections Investigator and research staff.
IRB-Investigator/ Research Coordinator Mtg. “CUMC’s New Progressive Policy For Adverse Event Reporting” April 13, 2004 George Gasparis Andrew Wit, Ph.D.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
CUMC IRB Investigator Meeting Human Subjects Research Non-Compliance September 15, 2005.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Renewing An Approved Protocol: IRB Review Process
Single Subject Protocol Modification Yale Human Research Protection Program * To play the presentation, click on this icon on the status bar below.
Brookhaven Science Associates U.S. Department of Energy 1 Brookhaven National Laboratory Protocol Compliance Monitoring Darcy Mallon May 7, 2009.
HRPP Policies & Forms Created/Revised for AAHRPP.
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
PRESENTING A PROTOCOL AN IRB INFOSHORT FEBRUARY 2013.
Continuing Review VA Requirements Kevin L. Nellis, M.S., M.T. (A.S.C.P.) Program Analyst Program for Research Integrity Development and Education (PRIDE)
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
SERIOUS ADVERSE EVENTS REPORTING Elizabeth Dayag IRB Administrator Naval Medical Center Portsmouth.
ORO Reviews: Frequent Findings Related to IRBs Bob Brooks Associate Director Research Compliance Education and Policy VHA Office of Research Oversight.
Reporting Unanticipated Problems and Adverse Events: A Change in Policy Mary A. Banks RN, BS, BSN Director, BUMC IRB Wednesday, November 14, 2007.
Unanticipated Problems Potentially Involving Risks to Subjects or Others Research Protections Office Serving UVM and FAHC Updated April 2012.
Reporting Adverse Events and Unanticipated Problems to the UAB IRB Policy and Procedure Change September 22, 2006 Amanda G. Murphy, RN, CIP Assistant Director,
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
Procedures and Forms 2008 FRCC Compliance Workshop April 8-9, 2008.
Adverse Event/Unanticipated Problems Policy and Procedures November 2007.
University of Miami Office of Research Compliance Assessment Lynn E. Smith, JD, CIM, CIP Johanna Stamates, RN, BA, CCRC With assistance from Elizabeth.
Monitoring IRB Monitoring of Clinical Trials. Types of Monitoring Internally Internally Externally Externally.
 The IRB application  The Review Process  Summary of Protocol  Appendixes  Informed Consent  Recruiting materials  Research Instruments  Other.
JERI R. BARNEY, JD HRPP COMPLIANCE MANAGER YALE UNIVERSITY HUMAN RESEARCH PROTECTION PROGRAM DECEMBER 13, 2012 Noncompliance.
I JUST SUBMITTED TO THE IRB… WHAT NOW?. HAVE I REALLY SUBMITTED IT?? (NOT IN THIS CASE - CLICK THE YELLOW BOX)
Continuing Review Presented by: Karen Jeans, PhD, CCRN, CIP Program Analyst, COACH.
VHA Research Compliance Reporting Requirements ORD Accreditation Conference Call December 15, 2011.
Investigational Devices and Humanitarian Use Devices June 2007.
HRPP Policies & Forms Chapter Two Created/Revised for AAHRPP June 1, 2007.
RIHES-II: H ANDLING A UDITS AND I NSPECTIONS E FFECTIVE D ATE 25 D ECEMBER 2006 V ERSION : 3.0 บุญเหลือ พรึงลำภู 15 มกราคม 2557.
© 2015 Marketo, Inc. Marketo Proprietary and Confidential Page 1 Investigators’ Responsibilities in Conducting Human Subjects Research Office of the Vice.
VA HRPP Accreditation October 18, 2011 Accreditation Conference Call PRIDE/Soundia Duche, MA, MS.
Non-compliance with Human Subjects Research Regulations J. Bruce Smith, MD, CIP November 2014 Continuing Education for IRB Members.
The TJU Human Research Protection Program (HRPP) Part II, Conflict of Interest and IRB Noncompliance J. Bruce Smith, MD, CIP.
Stanley Estime, MSCI QA/QI Specialist January 17, 2013 Reportable New Information.
Marianne M. Elliott Office of Research Integrity and Ethics Bureau of Medicine and Surgery U. S Navy.
THE INSTITUTIONAL REVIEW BOARD. WHAT IS AN IRB? An IRB is committee set up by an institution to review, approve, and regulate research conducted under.
Lifespan 1 Submission Process to the IRB part 2 Revisions to Protocol.
Slide 1 Standard Operating Procedures. Slide 2 Goal To review the standard operating procedures Creating the informed consent document Obtaining informed.
Responsibilities of Sponsor, Investigator and Monitor
Dartmouth Human Research Protection Program (HRPP) Data Safety Monitoring and Reporting requirements Brown Bag Series: Noon / First Tuesday of the Month.
Conditional IRB Approval
Responsibilities of Sponsor, Investigator and Monitor
Reportable Events Emory IRB 9/11/2014.
IRB reporting updates.
How to Put Together an IDE Application
What is a Data and Safety Monitoring Plan and how do I get one?
Reportable Events & Other IRB Updates February 2017
Reasons for Auditing There are many reasons for auditing. Some examples of these reasons might be: Requested by the IRB Committee Requested by an IRB.
Jeffrey M. Cohen, Ph.D. CIP President HRP Associates, Inc.
SERIOUS ADVERSE EVENTS REPORTING
Single Subject Protocol Modification
To start the presentation, click on this button in the lower right corner of your screen. The presentation will begin after the screen changes and you.
Reporting to the CPHS: Unanticipated Problems & Serious Adverse Events
Adverse Event Reporting
USF Research Integrity & Compliance
Policy on Prompt Reporting
Protocol Approval Criteria
Presentation transcript:

The HRPP FYI Process and the UPIRSO/SAE Review Sheet An IRB Infoshort February 2014

FYIs FYIs are notifications to the IRB regarding a specific research activity or event that does not invoke a standard protocol submission.

FYIs - 2 A variety of items are submitted to the IRB as For Your Information (FYI), rather than as applications. These include: UPIRSOs Adverse Events (internal and external) Subject complaints Noncomplianceprotocol deviations Breach of confidentiality (e.g., lost/stolen laptop) DSMB reports not associated with a re-approval application Other Yale review committee approvals (Radiation Safety, etc.) Certificates of Confidentiality

FYIs – 3 QA monitoring Visits or Audit reports FDA Notifications External IRB/Foreign IRB/equivalent notices and approvals Letters of support from Non-Government Organizations Signed agreements from participating schools Investigator brochures Publications Sponsor Close Out Visits

FYIs - 4 Some submissions (if received by the IRB) do not require IRB acknowledgment, unless requested by the investigator: Adverse events that do not meet our reporting requirements Non data-collection tools from sponsors (e.g., blank calendars for subjects) Public relations documents that do not require IRB review and approval Investigator brochure edits that are made to correct pagination, manufacturers address, etc.

The FYI Process The Regulatory Analyst reviews FYI notifications related to her committee and determines the level of review and response required. The submission May be returned to the researcher as unnecessary or incomplete May require a regulatory review May require review by the HRPP Compliance unit and/or Chair for additional action as deemed necessary.

The FYI Process - 2 If the FYI submission requires further information from the researcher, the regulatory analyst will request this information from the study team. For UPIRSOs and Adverse Events, the Regulatory Analyst will confirm whether the report meets the required criteria. This is documented on the UPIRSO & SAE Review Sheet.

UPIRSO/SAE Review Sheet (p.1)

UPIRSO/SAE Review Sheet (p. 2)

THE FYI Process - 3 If the required elements are not met, review by the IRB Chair or other qualified designee will not proceed, and the Regulatory Analyst will notify the researcher, providing education on required submission criteria.

The FYI Process - 4 If the confirmed report concerns an event that may be serious, unanticipated, and related to participation in the research study or an unanticipated problem that places, placed, or has the potential to place research subjects or others at risk of harm, then the report and any accompanying information is forwarded to the appropriate Chair, Vice-Chair or other qualified designee for review. The Chairperson or designee will determine if the report raises new concerns about risks and will recommend further review by the convened IRB, as necessary, for final determination.

The FYI Process – 5 If the Chair, Vice-Chair or other qualified designee determine that a submission requires full IRB Committee review, scheduling will be set. If the protocol has been scheduled for another action (e.g., annual renewal) the submission will be reviewed with that action. If there is no current action pending, the submission will be reviewed by the Committee as a stand-alone item.

The FYI Process - 6 The Committee will review the issue and will make a determination regarding whether is constitutes an unanticipated problem involving risks to subjects or others and if further action is necessary.